At 6.90% CAGR, Global Blood Transfusion Market Size to Surpass USD 6.1 billion by 2028 - Industry Trends, Share, Growth, Analysis & Forecast Report by Facts & Factors

The global market for blood transfusions was valued at USD 4.1 billion in 2021 and is projected to reach USD 6.1 billion by 2028, with a compound annual growth rate (CAGR) of roughly 6.90% during the forecast period, according to Facts and Factors. The study examines the forces that will shape the blood transfusion market throughout the forecast period, as well as its limitations and challenges. The paper also looks at new potential in the market for blood transfusions.

Blood or blood components are administered intravenously into the bloodstream during a transfusion. Transfusions are carried out for a number of medical conditions such as anemia, sickle cell disease, a bleeding issue like haemophilia, or cancer when the blood components are lost in order to maintain blood levels and the blood components in the body.

Blood transfusions involve the use of both one's own blood and other people's blood. The market is primarily driven by factors like the rise in accidents, trauma cases, surgeries, and blood disorders. The worldwide blood transfusion market is anticipated to expand at a CAGR of 6.90% during the forecast period due to the increase in demand for blood transfusion.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚𝐧 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 @https://www.fnfresearch.com/sample/blood-transfusion-market

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

𝐊𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐟𝐮𝐧𝐜𝐭𝐢𝐨𝐧𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐁𝐥𝐨𝐨𝐝 𝐓𝐫𝐚𝐧𝐬𝐟𝐮𝐬𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞
Immucor
Ortho Clinical Diagnostics
Abbott
Bio-Rad Laboratories
BAG Healthcare GmbH
DiaSorin S.P.A.
Danaher
BIO KIT (Werfen)
F. Hoffmann-La Roche AG
Quotient Limited.

The analysis of the blood transfusion business covers crucial market statistics and details. Based on historical data, the Blood Transfusion Market analysis provides main segments and sub-segments, revenue, and demand and supply information. the results of recent scientific efforts targeted at creating new products, industrial supply chains, suppliers, and manufacturing breakthroughs. The findings of this study are quite significant for the major players in the business.

𝐓𝐡𝐞 𝐁𝐥𝐨𝐨𝐝 𝐓𝐫𝐚𝐧𝐬𝐟𝐮𝐬𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐬 𝐭𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐬 𝐚𝐧𝐝 𝐦𝐚𝐣𝐨𝐫 𝐡𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬, 𝐚𝐦𝐨𝐧𝐠 𝐨𝐭𝐡𝐞𝐫𝐬:

The study offers a thorough overview of the worldwide blood transfusion market.
-Market dynamics in the business and on a global scale are evolving.
➛ Additionally, thorough market segmentation by kind and application is included in the report, along with regional analysis.
➛ There is a SWOT analysis for each significant player identified in the study report.

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭@https://www.fnfresearch.com/inquiry/blood-transfusion-market

Anaemia, leukopenia, leukocytosis, erythrocytosis, and thrombocytosis are becoming more common, which is promoting the market's expansion. The worldwide need for blood transfusions is rising as a result of severe casualties from natural catastrophes. The increased need for blood transfusions among children, adults, and elderly people is driving the global market. The adverse consequences of a blood transfusion system, including fever-inducing viruses and infections, allergic responses, and blood-borne diseases, are expected to limit market expansion. Lack of infrastructure and high-priced equipment is limiting the global market for blood transfusions in developing nations.

𝐃𝐢𝐯𝐢𝐬𝐢𝐨𝐧𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

Based on the product, application, end-use, and geography, the market for blood transfusions is segmented globally. The market is divided into three product categories: Reagents & Kits, Instruments, and Others. More than 65.8% of all sales worldwide in 2021 will be accounted for by the market for reagents & kits. The market is divided into Blood Grouping and Disease Screening categories based on application. The disease screening market is anticipated to grow at the quickest rate throughout the projected period and will represent more than 60% of global sales in 2021. The market is divided into Hospitals, Blood Banks, Diagnostic Laboratories, and Others based on end-use. In 2021, the hospital sector will control the market.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 @https://www.fnfresearch.com/blood-transfusion-market

𝐑𝐞𝐜𝐞𝐧𝐭 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In April 2021, EryPharm introduced a cutting-edge technique that can create red blood cells in enormous quantities and create new sources of blood for transfusions. The business intends to boost the production of Cultured Red Blood Cells (cRBC) using Hematopoietic Stem Cells by starting a pilot production phase (HSC).
In February 2019, the market for B2B IVD bulk reagents for blood grouping and latex serology testing was recently introduced by Torax Biosciences Limited. The company wants to offer its distribution partners, manufacturing businesses, or hospitals visible latex agglutination assays such as ASO, CRP, and RF, as well as blood grouping assays in filled or FFMU forms.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧@https://www.fnfresearch.com/customization/blood-transfusion-market

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭

Reagents & Kits
Instruments
Others

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Blood Grouping
Disease Screening

𝐁𝐲 𝐄𝐧𝐝-𝐮𝐬𝐞

Hospitals
Blood Banks
Diagnostic Laboratories
Others

𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧

North America
The U.S.
Canada
Mexico
Europe
France
The UK
Spain
Germany
Italy
Nordic Countries
Denmark
Sweden
Norway
Benelux Union
Belgium
The Netherlands
Luxembourg
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Southeast Asia
Indonesia
Thailand
Malaysia
Singapore
Rest of Southeast Asia
Rest of Asia Pacific
The Middle East & Africa
Saudi Arabia
UAE
Egypt
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America

𝐑𝐞𝐚𝐝 𝐃𝐞𝐭𝐚𝐢𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧@https://www.fnfresearch.com/blood-transfusion-market

𝐓𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭'𝐬 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐛𝐣𝐞𝐜𝐭𝐢𝐯𝐞𝐬:

To estimate the size of each segment within the global blood transfusion market.
To estimate the size and future prospects of the world's blood transfusion market based on important variables.
To take into account the key stakeholders and their long-term development plans.
To research the global blood transfusion market's growth trends, business possibilities, and general level of interest.
To utilize information about the organization, important regions/nations, goods, and applications to estimating the size of the global blood transfusion market (in volume and value terms).
Important data on market growth, SWOT analysis, and long-term improvement goals, as well as market share, company size, and industry segments for the global blood transfusion market.

Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: sales@fnfresearch.com
Web: https://www.fnfresearch.com

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client's/customer's conviction in our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

This release was published on openPR.